Long-term effects of hormone replacement therapy

Slides:



Advertisements
Similar presentations
Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies  Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.
Volume 367, Issue 9517, Pages (April 2006)
Volume 357, Issue 9257, Pages (March 2001)
Volume 359, Issue 9322, Pages (June 2002)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.
Volume 376, Issue 9734, Pages (July 2010)
Thank God for Richard Dawkins?
Meta-analysis of randomised controlled trials
Infections related to totally implantable venous-access ports
Low-level laser therapy for neck pain
Volume 376, Issue 9734, Pages (July 2010)
Frailty assessment in elderly people
Physical activity and prevention of type 2 diabetes
Long-term effects of hormone replacement therapy
Pralidoxime for organophosphate poisoning
Gareth L Ackland, Maurizio Cecconi, Rupert M Pearse 
Underestimate of annual malaria imports to Canada – Author reply
Political factors behind US global AIDS programmes slow-down
Volume 1, Issue 3, Pages (August 2014)
Hormones and bones The Lancet Volume 349, Pages S20-S23 (March 1997)
Aspirin in the prevention of cancer – Author's reply
Do air quality alerts benefit public health? New evidence from Canada
Volume 375, Issue 9732, Pages (June 2010)
Expanding perception through the disordered brain
Drug therapy for coronary heart disease: the Sheffield table
Gene therapy—where are we?
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.
Volume 372, Issue 9642, Pages (September 2008)
Ana Victoria Roman, Wilton Perez, Richard Smith  The Lancet 
SNPs and coronary heart disease – Authors' reply
INSIGHT and NORDIL The Lancet
Non-communicable disease priority actions and social inclusion
Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study  Rachel F Simpson, MB BCh, Carol Hermon, MSc, Bette.
Disease and stigma The Lancet Volume 354, (December 1999)
Mortality risk with dual antiplatelet therapy?
Arnaud Chiolero  The Lancet Public Health 
HIV myths should not be resuscitated
Volume 352, Pages S15-S18 (October 1998)
Bruce Neal, Fiona Turnbull  The Lancet 
MRC/BHF Heart Protection Study
Volume 375, Issue 9709, Pages (January 2010)
Confessions of a journal junkie
Infant-feeding patterns and HIV-1 transmission
Volume 371, Issue 9627, Pages (May 2008)
Telling it like it isn't: truth and lies in a post-9/11 world
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study  Heart Protection.
Thank God for Richard Dawkins?
Department of Error The Lancet Volume 369, Issue 9564, (March 2007)
Low-technology approaches
UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years  Richard Peto, Jillian Boreham, Mike Clarke, Christina Davies, Valerie Beral 
Volume 361, Issue 9352, Pages (January 2003)
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
Volume 377, Issue 9777, Pages (May 2011)
Volume 383, Issue 9921, Pages (March 2014)
Vitamin D status and ill health – Author's reply
Costs of eliminating HIV in South Africa have been underestimated
Infections related to totally implantable venous-access ports
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised.
A remarkable report card on progress in COPD
Difficulties of surgery in the developing world: a personal view
Political factors behind US global AIDS programmes slow-down
ECASS-II: intravenous alteplase in acute ischaemic stroke
Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,
Menopausal hormone therapy and 20-year breast cancer mortality
Symptom-based stratification of autoimmune diseases
Sickle cell disease: a new era
Autism, maths, and sex: the special triangle
Presentation transcript:

Long-term effects of hormone replacement therapy Valerie Beral, Emily Banks, Gillian Reeves  The Lancet  Volume 361, Issue 9353, Pages 254-255 (January 2003) DOI: 10.1016/S0140-6736(03)12281-7 Copyright © 2003 Elsevier Ltd Terms and Conditions

Figure Relative risk of coronary heart disease in HRT users compared with non-users from major randomised trials of HRT, according to type of regimen used The Lancet 2003 361, 254-255DOI: (10.1016/S0140-6736(03)12281-7) Copyright © 2003 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.